NCT02591849View on ClinicalTrials.gov

GLP-1 Effects on Insulin and Glucagon in PTDM

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Post-transplant Diabetes Mellitus
Interventions
DIETARY_SUPPLEMENT

Glucagon-like peptide-1 (GLP-1)

OTHER

Isotonic saline

OTHER

Hyperglycemic clamp

Trial Locations (1)

N-0424

Oslo University Hospital, Rikshospitalet, Oslo

All Listed Sponsors
lead

Oslo University Hospital

OTHER

NCT02591849 - GLP-1 Effects on Insulin and Glucagon in PTDM | Biotech Hunter | Biotech Hunter